1-(1,3-Dimethyl-1H-pyrazol-4-yl)-ethanone, 95.0%, 250mg

Ethyl 4,4-dimethyl-3-oxopentanoate, 95.0%, 500g

(R)-tert-Butyl (2-oxopiperidin-3-yl)carbamate, 95.0%, 5g

(2E)-3-(2-fluorophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4-BROMO-2-PYRROLIDIN-2-YL-PYRIDINE, 95%, 250mg

1-Methyl-4-[2-nitro-4-(trifluoromethyl)phenyl]piperazine hydrochloride, 1g

(R)-2-((1-Phenylethyl)carbamoyl)benzoic acid, 95.0%, 1g

(4-Methoxyphenyl)urea>98.0%(HPLC)(N)1g

DL-alpha-tocopherol, min. 96%, Ph.Eur., oily, 250 g, glass packaging

Piperazine DL-Malate>98.0%(T)25g

MTIC, 100mg

(2S,4R)-4-METHOXY-2-METHYLPIPERIDINE HYDROCHLORIDE, 95%, 1g

4,6-Dichloro-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one, 95.0%, 5g